Lower risk Drug recall · FDA · Published March 16, 2026

Meclizine 12.5mg Tablets Recall: Failed Tablet Specifications

Amerisource Health Services recalls 12.5mg Meclizine tablets due to failed specifications. This affects certain lots and requires checking your product details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0418-2026Drug Amerisource Health Services ›

Lower-risk recall

Failed tablet specifications.

Take action

Contact the company

Recalling firmAmerisource Health Services LLC2550 John Glenn Ave Ste A · Columbus, OH 43217-1188

✎ GovInfoNow plain-language explainer

Amerisource Health Services is recalling 12.5mg Meclizine Hydrochloride Tablets that failed quality specifications. This recall affects specific lots and product types sold through pharmacies. Read more at govinfonow.com/recall/31431-meclizine-12-5mg-tablets-recall-failed-tablet-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/31431-meclizine-12-5mg-tablets-recall-failed-tablet-specifications · Updated August 17, 2026 · FDA enforcement record: FDA #D-0418-2026

Cite this page

“Meclizine 12.5mg Tablets Recall: Failed Tablet Specifications.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31431-meclizine-12-5mg-tablets-recall-failed-tablet-specifications. Based on FDA recall #D-0418-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0418-2026%22&limit=1).

Amerisource Health Services LLC voluntarily recalled Meclizine Hydrochloride Tablets, USP 12.5 mg due to failed tablet specifications, the FDA said on March 16, 2026.

How to tell if you have it

Brand: Amerisource Health Services
Product: Meclizine Hydrochloride Tablets, USP 12.5 mg
NDC 60687-775-65 (50 Tablets [5 x 10])
NDC 60687-775-11 (12.5 mg Individual Dose)
Lot #1024852
Expiration: 9/30/2026
Distributed by: American Health Packaging, Columbus, Ohio, 43217

The hazard

The recall involves failed tablet specifications. The FDA announced the Class II recall of 697 cartons distributed nationwide.

Context

GovInfoNow's records show Amerisource Health Services LLC has 30 other recalls on record since 2022-07-27. Other recent recalls by this brand include a Primidone Tablets recall for cross contamination risk on 2026-05-01 and an Oxycodone 5mg Tablets recall for weak blister seals on 2026-01-14.

How to tell if you have this one

Check for the product name 'Meclizine Hydrochloride Tablets, USP 12.5 mg' with NDC numbers 60687-775-65 or 60687-775-11. These were distributed by American Health Packaging in Columbus, Ohio.

Brand
Amerisource Health Services
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for the NDC numbers 60687-775-65 or 60687-775-11 on the tablet packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 16 days after the firm started it.

Mar 16, 2026Firm started the recall
Mar 31, 2026FDA classified it Class II
Apr 1, 2026Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Do I need to stop using these tablets?

The recall does not require stopping use; it's a quality issue that may affect dosing consistency.

Similar recalls

Other Amerisource Health Services recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/31431-meclizine-12-5mg-tablets-recall-failed-tablet-specifications">Meclizine 12.5mg Tablets Recall: Failed Tablet Specifications (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0418-2026 (March 16, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0418-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.